Article Versions Notes

Anguera G, Mulet M, Zamora C, Osuna-Gómez R, Barba A, Sullivan I, Serra-López J, Cantó E, Vidal S, Majem M. Potential Role of Circulating PD-L1⁺ Leukocytes as a Predictor of Response to Anti-PD-(L)1 Therapy in NSCLC Patients. Biomedicines. 2024; 12(5):958. https://doi.org/10.3390/biomedicines12050958

Anguera, Georgia, Maria Mulet, Carlos Zamora, Rubén Osuna-Gómez, Andrés Barba, Ivana Sullivan, Jorgina Serra-López, Elisabet Cantó, Silvia Vidal, and Margarita Majem. 2024. "Potential Role of Circulating PD-L1⁺ Leukocytes as a Predictor of Response to Anti-PD-(L)1 Therapy in NSCLC Patients" Biomedicines 12, no. 5: 958. https://doi.org/10.3390/biomedicines12050958

Anguera, G., Mulet, M., Zamora, C., Osuna-Gómez, R., Barba, A., Sullivan, I., Serra-López, J., Cantó, E., Vidal, S., & Majem, M. (2024). Potential Role of Circulating PD-L1⁺ Leukocytes as a Predictor of Response to Anti-PD-(L)1 Therapy in NSCLC Patients. Biomedicines, 12(5), 958. https://doi.org/10.3390/biomedicines12050958